Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $71.8M; returns 1 day +0.4%, 1 week +0.8%, 1 year -57.4%.

Oncolytics Biotech Inc. (ONCY) is a clinical-stage biotechnology company focused on developing pelareorep, an intravenously delivered double-stranded RNA immunotherapeutic agent designed to activate the immune system against cancer. The company is advancing pelareorep primarily in metastatic pancreatic and breast cancers, both of which have received Fast Track designation from the U.S.

Groups ONCY belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Healthcare
• Life Sciences
• Biopharmaceutical
• Breast Cancer Treatment
• Pancreatic Cancer
• Gastroenterology
• Fast Track Designation

ONCY financial model: income statement, cash flow and balance sheet